Ernexa Therapeutics Inc (ERNA): Next-Year EPS Estimate 89.68%
As of 2026-06-28, Ernexa Therapeutics Inc (ERNA) has a next-year EPS growth estimate of 89.68%. Featured in 3 EPS revision reports, most recently on 2026-05-19.
On 2026-05-28, analyst consensus for ERNA's next-year EPS growth shifted from 87.42% to 89.68% — a positive change of 2.26 percentage points. The revised estimate has been sustained across 22 subsequent trading sessions. Current-year growth is projected at 67.76%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 89.68%
- EPS growth this year
- 67.76%
- EPS next quarter (est)
- -$3.30
- Last price
- $6.97
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-28 | 89.68% | 67.76% | -$3.30 | $6.97 |
| 2026-06-25 | 89.68% | 67.76% | -$3.30 | $7.40 |
| 2026-06-24 | 89.68% | 67.76% | -$3.30 | $6.30 |
| 2026-06-23 | 89.68% | 67.76% | -$3.30 | $6.18 |
| 2026-06-22 | 89.68% | 67.76% | -$3.30 | $5.89 |
| 2026-06-21 | 89.68% | 67.76% | -$3.30 | $6.20 |
| 2026-06-18 | 89.68% | 67.76% | -$3.30 | $6.20 |
| 2026-06-17 | 89.68% | 67.76% | -$3.30 | $5.89 |
| 2026-06-16 | 89.68% | 67.76% | -$3.30 | $6.10 |
| 2026-06-15 | 89.68% | 67.76% | -$3.30 | $6.30 |
| 2026-06-14 | 89.68% | 67.76% | -$3.30 | $6.15 |
| 2026-06-11 | 89.68% | 67.76% | -$3.30 | $6.55 |
| 2026-06-10 | 89.68% | 67.76% | -$3.30 | $6.34 |
| 2026-06-09 | 89.68% | 67.76% | -$3.30 | $6.80 |
| 2026-06-08 | 89.68% | 67.76% | -$3.30 | $7.39 |
| 2026-06-07 | 89.68% | 67.76% | -$3.30 | $7.89 |
| 2026-06-04 | 89.68% | 67.76% | -$3.30 | $8.19 |
| 2026-06-03 | 89.68% | 67.76% | -$3.30 | $8.01 |
| 2026-06-02 | 89.68% | 67.76% | -$3.30 | $8.00 |
| 2026-06-01 | 89.68% | 67.76% | -$3.30 | $9.12 |
| 2026-05-31 | 89.68% | 67.76% | -$3.30 | $10.57 |
| 2026-05-28 | 89.68% | 67.76% | N/A | $11.66 |
| 2026-05-27 | 87.42% | 83.22% | N/A | $11.14 |
| 2026-05-26 | 87.42% | 83.22% | N/A | $11.43 |
| 2026-05-25 | 87.42% | 83.22% | N/A | $11.99 |
| 2026-05-24 | 87.42% | 83.22% | N/A | $11.99 |
| 2026-05-21 | 87.42% | 83.22% | N/A | $12.46 |
| 2026-05-20 | 87.42% | 83.22% | N/A | $11.40 |
| 2026-05-19 | 87.42% | 83.22% | N/A | $11.45 |
| 2026-05-18 | 87.42% | 83.22% | N/A | $12.25 |
Reports Featuring ERNA
Screen Performance
Aggregate stats across all 1814 tickers our top-EPS-revision screen has flagged over the past 88 days.
- Median return since detection
- +4.8%
- % of tickers in the green
- 60%
- Median return on winners
- +19.5%
- Large revisions captured
- 897
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Ernexa Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-28, Ernexa Therapeutics Inc (ERNA) has a next-year EPS growth estimate of 89.68%, based on analyst consensus.
When was the latest EPS estimate revision for ERNA?▾
The most recent revision occurred on 2026-05-28, when analysts adjusted the next-year EPS growth estimate from 87.42% to 89.68%.
What sector and industry does Ernexa Therapeutics Inc belong to?▾
Ernexa Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ERNA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Ernexa Therapeutics Inc (ERNA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports